1. Home
  2. GH vs ABCB Comparison

GH vs ABCB Comparison

Compare GH & ABCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GH
  • ABCB
  • Stock Information
  • Founded
  • GH 2011
  • ABCB 1971
  • Country
  • GH United States
  • ABCB United States
  • Employees
  • GH N/A
  • ABCB N/A
  • Industry
  • GH Medical Specialities
  • ABCB Major Banks
  • Sector
  • GH Health Care
  • ABCB Finance
  • Exchange
  • GH Nasdaq
  • ABCB Nasdaq
  • Market Cap
  • GH 4.7B
  • ABCB 4.4B
  • IPO Year
  • GH 2018
  • ABCB N/A
  • Fundamental
  • Price
  • GH $45.13
  • ABCB $65.65
  • Analyst Decision
  • GH Strong Buy
  • ABCB Buy
  • Analyst Count
  • GH 14
  • ABCB 6
  • Target Price
  • GH $39.93
  • ABCB $66.83
  • AVG Volume (30 Days)
  • GH 1.9M
  • ABCB 447.9K
  • Earning Date
  • GH 02-20-2025
  • ABCB 01-30-2025
  • Dividend Yield
  • GH N/A
  • ABCB 0.91%
  • EPS Growth
  • GH N/A
  • ABCB 16.00
  • EPS
  • GH N/A
  • ABCB 4.78
  • Revenue
  • GH $692,256,000.00
  • ABCB $1,046,982,000.00
  • Revenue This Year
  • GH $32.21
  • ABCB N/A
  • Revenue Next Year
  • GH $16.90
  • ABCB $5.73
  • P/E Ratio
  • GH N/A
  • ABCB $13.75
  • Revenue Growth
  • GH 29.20
  • ABCB 11.92
  • 52 Week Low
  • GH $15.81
  • ABCB $44.23
  • 52 Week High
  • GH $45.66
  • ABCB $74.56
  • Technical
  • Relative Strength Index (RSI)
  • GH 79.68
  • ABCB 57.48
  • Support Level
  • GH $36.45
  • ABCB $58.65
  • Resistance Level
  • GH $39.29
  • ABCB $65.29
  • Average True Range (ATR)
  • GH 2.35
  • ABCB 1.53
  • MACD
  • GH 0.75
  • ABCB 0.61
  • Stochastic Oscillator
  • GH 96.63
  • ABCB 90.03

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About ABCB Ameris Bancorp

Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into five segments: banking, retail mortgage, warehouse lending, SBA, and premium finance. The company generates most of its revenue from the banking segment. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.

Share on Social Networks: